These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15280657)

  • 1. Actvation of NF-kappaB by the API2/MALT1 fusions inhibits p53 dependant but not FAS induced apoptosis: a directional link between NF-kappaB and p53.
    Stoffel A; Levine AJ
    Cell Cycle; 2004 Aug; 3(8):1017-20. PubMed ID: 15280657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of NF-kappaB and inhibition of p53-mediated apoptosis by API2/mucosa-associated lymphoid tissue 1 fusions promote oncogenesis.
    Stoffel A; Chaurushiya M; Singh B; Levine AJ
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9079-84. PubMed ID: 15184680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells.
    Ho L; Davis RE; Conne B; Chappuis R; Berczy M; Mhawech P; Staudt LM; Schwaller J
    Blood; 2005 Apr; 105(7):2891-9. PubMed ID: 15598810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.
    Hosokawa Y
    Apoptosis; 2005 Jan; 10(1):25-34. PubMed ID: 15711920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dual role for the API2 moiety in API2-MALT1-dependent NF-kappaB activation: heterotypic oligomerization and TRAF2 recruitment.
    Lucas PC; Kuffa P; Gu S; Kohrt D; Kim DS; Siu K; Jin X; Swenson J; McAllister-Lucas LM
    Oncogene; 2007 Aug; 26(38):5643-54. PubMed ID: 17334391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions.
    Noels H; van Loo G; Hagens S; Broeckx V; Beyaert R; Marynen P; Baens M
    J Biol Chem; 2007 Apr; 282(14):10180-9. PubMed ID: 17287209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability and subcellular localization of API2-MALT1 chimeric protein involved in t(11;18) (q21;q21) MALT lymphoma.
    Izumiyama K; Nakagawa M; Yonezumi M; Kasugai Y; Suzuki R; Suzuki H; Tsuzuki S; Hosokawa Y; Asaka M; Seto M
    Oncogene; 2003 Nov; 22(50):8085-92. PubMed ID: 14603249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. API2-MALT1 fusion protein induces transcriptional activation of the API2 gene through NF-kappaB binding elements: evidence for a positive feed-back loop pathway resulting in unremitting NF-kappaB activation.
    Hosokawa Y; Suzuki H; Nakagawa M; Lee TH; Seto M
    Biochem Biophys Res Commun; 2005 Aug; 334(1):51-60. PubMed ID: 15982633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathogenesis of MALT lymphoma: two signaling pathways underlying the antiapoptotic effect of API2-MALT1 fusion protein.
    Nakagawa M; Seto M; Hosokawa Y
    Leukemia; 2006 Jun; 20(6):929-36. PubMed ID: 16572204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. API2-MALT1 oncoprotein promotes lymphomagenesis via unique program of substrate ubiquitination and proteolysis.
    Rosebeck S; Lim MS; Elenitoba-Johnson KS; McAllister-Lucas LM; Lucas PC
    World J Biol Chem; 2016 Feb; 7(1):128-37. PubMed ID: 26981201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiapoptotic function of apoptosis inhibitor 2-MALT1 fusion protein involved in t(11;18)(q21;q21) mucosa-associated lymphoid tissue lymphoma.
    Hosokawa Y; Suzuki H; Suzuki Y; Takahashi R; Seto M
    Cancer Res; 2004 May; 64(10):3452-7. PubMed ID: 15150097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The API2-MALT1 fusion exploits TNFR pathway-associated RIP1 ubiquitination to promote oncogenic NF-κB signaling.
    Rosebeck S; Rehman AO; Apel IJ; Kohrt D; Appert A; O'Donnell MA; Ting AT; Du MQ; Baens M; Lucas PC; McAllister-Lucas LM
    Oncogene; 2014 May; 33(19):2520-30. PubMed ID: 23770847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease activity of the API2-MALT1 fusion oncoprotein in MALT lymphoma development and treatment.
    Rosebeck S; Lucas PC; McAllister-Lucas LM
    Future Oncol; 2011 May; 7(5):613-7. PubMed ID: 21568677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective expansion of marginal zone B cells in Emicro-API2-MALT1 mice is linked to enhanced IkappaB kinase gamma polyubiquitination.
    Baens M; Fevery S; Sagaert X; Noels H; Hagens S; Broeckx V; Billiau AD; De Wolf-Peeters C; Marynen P
    Cancer Res; 2006 May; 66(10):5270-7. PubMed ID: 16707452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The API2/MALT1 fusion product may lead to germinal center B cell lymphomas by suppression of apoptosis.
    Stoffel A; Le Beau MM
    Hum Hered; 2001; 51(1-2):1-7. PubMed ID: 11096264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor kappaB activation and antiapoptosis in mucosa-associated lymphoid tissue lymphoma.
    Hosokawa Y; Seto M
    Int J Hematol; 2004 Oct; 80(3):215-23. PubMed ID: 15540895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by API2-MALT1 in MALT lymphoma.
    Nie Z; Du MQ; McAllister-Lucas LM; Lucas PC; Bailey NG; Hogaboam CM; Lim MS; Elenitoba-Johnson KS
    Nat Commun; 2015 Jan; 6():5908. PubMed ID: 25569716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.
    Garrison JB; Samuel T; Reed JC
    Oncogene; 2009 Apr; 28(13):1584-93. PubMed ID: 19234489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogene-induced MALT1 protease activity drives posttranscriptional gene expression in malignant lymphomas.
    Wimberger N; Ober F; Avar G; Grau M; Xu W; Lenz G; Menden MP; Krappmann D
    Blood; 2023 Dec; 142(23):1985-2001. PubMed ID: 37623434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation.
    Rosebeck S; Madden L; Jin X; Gu S; Apel IJ; Appert A; Hamoudi RA; Noels H; Sagaert X; Van Loo P; Baens M; Du MQ; Lucas PC; McAllister-Lucas LM
    Science; 2011 Jan; 331(6016):468-72. PubMed ID: 21273489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.